Abstract

A new insight on feasibility of pre-, pro-, and synbiotics-based therapies in Alzheimer’s disease

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call